arrow
朱

朱益 (Yi Zhu)

Mayo Clinic
H指数:39
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Senloytics, dasatinib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease

Senloyatics,达沙替尼加槲皮素,减少肾脏炎症,衰老细胞丰度和损伤,同时恢复小鼠糖尿病肾病的老年保护因子

2026-01-200
OAAI
Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers
2026-01-010
OAAI
Endothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice

内皮衰老细胞特异性清除缓解肥胖小鼠的代谢功能障碍

2025-11-200
PRE
IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity

负载IL-2的脂质体经索拉非尼衍生物修饰后,可通过改善肿瘤免疫微环境并增强抗血管生成活性,发挥协同抗黑色素瘤作用。

2025-01-010
OAAI
Local senolysis in aged mice only partially replicates the benefits of systemic senolysis

老年小鼠的局部衰老仅部分复制了全身性衰老的益处

2023-04-1727
OAAI
Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance

通过p16-positive的衰老细胞清除使小鼠的衰老脑免疫细胞景观恢复活力

2022-09-2748
OAAI
Orally-active, clinically-translatable senolytics restore a-Klotho in mice and humans
2022-03-0143
OAAI
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
2022-02-2133
OAAI
Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era

非瑟汀在专业护理机构中的新型冠状病毒肺炎: COVID时代的抗衰老试验

2021-08-2037
OA